Literature DB >> 9693155

Immunopathogenesis of Mycobacterium avium infection.

A M Cooper1, R Appelberg, I M Orme.   

Abstract

One of the most obvious problems one perceives when working with Mycobacterium avium isolates is the vast array of phenotypes expressed with regard to colonial morphotype, serovar and particularly virulence. Thus whenever experimental data derived from different MAC isolates is compared the variety of this group of mycobacteria must always be considered. Another issue of concern is the extrapolation of in vitro data to the in vivo disease. We have reported, in the past, that survival in murine macrophage culture does not always correlate with survival in vivo (23). It is plausible therefore, that the pathways outlined in section 5.2 and figure 3 play a crucial role in the initiation of the innate immune response in general and that there are components of this response which are not expressed by IFN-gamma activated macrophages but which are necessary for bacterial control. In conclusion, we suggest that the initial control of MAC infection requires a healthy lung (or gut) architecture and that control by unactivated macrophages includes respiratory burst activity and also the sequestration of free iron away from the mycobacterial phagosome. Acquired immunity is important in controlling bacteria which have overcome the innate response and this control is mediated by cytokine activation of infected macrophages. Finally, we have described an animal model of infection in which uncontrolled bacterial growth occurs and in which lesions similar to those seen in AIDS patients develop.

Entities:  

Mesh:

Year:  1998        PMID: 9693155     DOI: 10.2741/a287

Source DB:  PubMed          Journal:  Front Biosci        ISSN: 1093-4715


  9 in total

1.  Comparative protective effects of recombinant DNA and Mycobacterium bovis bacille Calmette-Guérin vaccines against M. avium infection.

Authors:  E Martin; J A Triccas; A T Kamath; N Winter; W J Britton
Journal:  Clin Exp Immunol       Date:  2001-12       Impact factor: 4.330

2.  Common and unique gene expression signatures of human macrophages in response to four strains of Mycobacterium avium that differ in their growth and persistence characteristics.

Authors:  Antje Blumenthal; Jörg Lauber; Reinhard Hoffmann; Martin Ernst; Christine Keller; Jan Buer; Stefan Ehlers; Norbert Reiling
Journal:  Infect Immun       Date:  2005-06       Impact factor: 3.441

Review 3.  Exploring immunomodulation by endocrine changes in Lady Windermere syndrome.

Authors:  M R Holt; J J Miles; W J Inder; R M Thomson
Journal:  Clin Exp Immunol       Date:  2019-02-27       Impact factor: 4.330

4.  Dynamics of immune effector mechanisms during infection with Mycobacterium avium in C57BL/6 mice.

Authors:  Markus Haug; Jane A Awuh; Magnus Steigedal; June Frengen Kojen; Anne Marstad; Ivar S Nordrum; Øyvind Halaas; Trude H Flo
Journal:  Immunology       Date:  2013-10       Impact factor: 7.397

5.  Protection against virulent Mycobacterium avium infection following DNA vaccination with the 35-kilodalton antigen is accompanied by induction of gamma interferon-secreting CD4(+) T cells.

Authors:  E Martin; A T Kamath; J A Triccas; W J Britton
Journal:  Infect Immun       Date:  2000-06       Impact factor: 3.441

Review 6.  Health impacts of environmental mycobacteria.

Authors:  Todd P Primm; Christie A Lucero; Joseph O Falkinham
Journal:  Clin Microbiol Rev       Date:  2004-01       Impact factor: 26.132

7.  Host response to nontuberculous mycobacterial infections of current clinical importance.

Authors:  Ian M Orme; Diane J Ordway
Journal:  Infect Immun       Date:  2014-06-09       Impact factor: 3.441

8.  A Rhesus Macaque Model of Pulmonary Nontuberculous Mycobacterial Disease.

Authors:  Kevin Winthrop; Andrea Rivera; Flora Engelmann; Sasha Rose; Anne Lewis; Jennifer Ku; Luiz Bermudez; Ilhem Messaoudi
Journal:  Am J Respir Cell Mol Biol       Date:  2016-02       Impact factor: 6.914

9.  Mycobacterium avium genes expressed during growth in human macrophages detected by selective capture of transcribed sequences (SCOTS).

Authors:  Joan Y Hou; James E Graham; Josephine E Clark-Curtiss
Journal:  Infect Immun       Date:  2002-07       Impact factor: 3.441

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.